Gynecologic Extramammary Paget's Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMayo Clinic

About this trial

In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Females

Age 18 years or older

Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body

Willing and able to provide signed informed consent

Disqualifiers

Males

Diagnosis of Paget's Disease in body areas other than vulvar or perianal region

Trial population

Women diagnosed with Extramammary Paget's Disease

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 1 trial group
Group A: Registry Observational Study

Trial outcomes

Primary outcomes

1

Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD).

Prospective data including patient demographic information, surgical outcomes, surgical morbidity, recurrence, and long-term survival in extramammary Paget's disease (EMPD) will be collected as part of this registry..

Time frame
25 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.